logo
logo
AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + proprietary hiring database
✓Executive contact details included
INDUSTRY FIRST

Paragon Therapeutics Appoints Susanna High As Chief Executive Officer

Nov 21, 2024•9 months ago

Position

Chief Executive Officer

Company

Paragon Therapeutics

Susanna High
WalthamTherapeuticsBiotechnology

Description

Susanna High, MBA, has been appointed as Chief Executive Officer at Paragon Therapeutics, where she will lead the team's efforts to propel the development of transformative therapies and accelerate their potential impact. High brings deep strategic and operational experience in building and leading fast-growing innovative biotech companies.

Company Information

Company

Paragon Therapeutics

Location

Waltham, Massachusetts, United States

About

Paragon Therapeutics, Inc., is a biotechnology company applying cutting-edge science and technology to shape the next generation of novel best-in-class complex biologics for major medical needs. The company is fueling a pipeline of transformative therapies and rapidly advancing them into clinical development. Founded by Fairmount in 2021, Paragon is based in Waltham, MA.

Company News

(6 articles)
Thu, 21 Nov 2024 08:00:00 GMT

Paragon Therapeutics Appoints Susanna High as Chief Executive Officer - PR Newswire

Thu, 21 Aug 2025 17:30:00 GMT

Paragon Therapeutics Expands Executive Team to Advance Strategic Objectives - PR Newswire

Tue, 29 Aug 2023 07:00:00 GMT

Paragon Therapeutics Recognizes Key Milestones and Leadership Appointment for First Spinout, Apogee Therapeutics - PR Newswire

Wed, 03 Apr 2024 07:00:00 GMT

Paragon Therapeutics Announces Oruka Therapeutics Has Entered into Merger Agreement with ARCA biopharma to Advance Novel Treatments for Chronic Skin Diseases - PR Newswire

Tue, 20 Jul 2021 07:00:00 GMT

Paragon Therapeutics Announces Antibody Discovery Joint Venture with FairJourney Biologics - PR Newswire

Thu, 01 Aug 2024 07:00:00 GMT

Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases - PR Newswire

FundzWatch™ Score

12
Medium Activity
2 total signals

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months